Informally, but conveniently, Ihub actually provides OS and float information.
Click on the graph at the top of the message displays on our board.
Click on the link for "more quote information" at the bottom of the matrix that will be displayed.
The following displays:
Market Cap $ 1.09B
Shares in Issue 58.66M
Float 37.37M
As far as PE Ratio, Investopedia writes that, "As of March 2015, the drugs sector has an average P/E ratio of 24.10." It is a dated article, but that ratio is as good as any.
I would just suggest that you use earnings that represent half of revenues. But, if the international market has lower costs per day for hospitalization, we may not get them to buy at $10K per treatment. On the other hand, I think our manufacturing costs are well below what it would take to earn 50%.
We really need guidance from management which should now be much more in focus, now that we have reached our primary endpoint and Durrant has an informed opinion of market demand. We could be seeing the 10-Q anytime within the next 10 days, and it's possible that we could see management update the projected revenue.
Market Data 
Markets 
AI
